.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Merck
Harvard Business School
Moodys
Citi
Farmers Insurance
Baxter
Accenture
QuintilesIMS
Fish and Richardson

Generated: June 25, 2017

DrugPatentWatch Database Preview

Didanosine - Generic Drug Details

« Back to Dashboard

What are the generic sources for didanosine and what is the scope of didanosine freedom to operate?

Didanosine
is the generic ingredient in three branded drugs marketed by Aurobindo Pharma, Bristol Myers Squibb, Barr, Aurobindo, and Mylan Pharms Inc, and is included in nine NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for didanosine. Five suppliers are listed for this compound.

Summary for Generic Name: didanosine

Tradenames:3
Patents:1
Applicants:5
NDAs:9
Drug Master File Entries: see list8
Suppliers / Packagers: see list5
Bulk Api Vendors: see list78
Clinical Trials: see list144
Patent Applications: see list6,215
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:didanosine at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo
DIDANOSINE
didanosine
TABLET, FOR SUSPENSION;ORAL077275-002Aug 14, 2012RXNoNo► Subscribe► Subscribe
Bristol Myers Squibb
VIDEX EC
didanosine
CAPSULE, DELAYED REL PELLETS;ORAL021183-001Oct 31, 2000ABRXYesNo► Subscribe► Subscribe
Mylan Pharms Inc
DIDANOSINE
didanosine
CAPSULE, DELAYED REL PELLETS;ORAL090788-002Apr 8, 2010DISCNNoNo► Subscribe► Subscribe
Aurobindo Pharma
DIDANOSINE
didanosine
CAPSULE, DELAYED REL PELLETS;ORAL090094-001Sep 24, 2008ABRXNoNo► Subscribe► Subscribe
Bristol Myers Squibb
VIDEX
didanosine
FOR SOLUTION;ORAL020156-001Oct 9, 1991AARXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: didanosine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb
VIDEX
didanosine
TABLET, CHEWABLE;ORAL020154-002Oct 9, 19915,880,106*PED► Subscribe
Bristol Myers Squibb
VIDEX
didanosine
FOR SOLUTION;ORAL020155-003Oct 9, 19915,254,539*PED► Subscribe
Bristol Myers Squibb
VIDEX
didanosine
FOR SOLUTION;ORAL020155-003Oct 9, 19914,861,759*PED► Subscribe
Bristol Myers Squibb
VIDEX
didanosine
FOR SOLUTION;ORAL020155-003Oct 9, 19915,616,566*PED► Subscribe
Bristol Myers Squibb
VIDEX
didanosine
TABLET, CHEWABLE;ORAL020154-005Oct 9, 19915,616,566*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Argus Health
Cipla
Novartis
Chinese Patent Office
McKesson
Harvard Business School
Julphar
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot